<rss version="2.0">
<channel>
<title>IBTimes.com RSS Feed - GILD</title>
<description>International Business News - GILD</description>
<link>http://www.ibtimes.com</link>
<copyright>All articles are copyrighted by IBTimes.com</copyright>

<image>
	<title>The International Business Times - Business News, Updated daily</title> 
	<width>400</width> 
	<height>100</height> 
	<link>http://www.ibtimes.com/</link> 
	<url>http://www.ibtimes.com/images/top_logo_ibt2_3.gif</url> 
</image>


  <item>
  <title>Gilead shares rise as new HIV study begins</title>
  <description>Shares of biotechnology company Gilead Sciences Inc. rose Wednesday after the company said it started a late-stage study of a new HIV treatment candidate.</description>
    <link>http://www.ibtimes.com/articles/20080723/gilead-shares-rise-as-new-hiv-study-begins.htm</link> 
  <pubDate>Wed, 23 Jul 2008 14:30:23 EDT</pubDate>
  </item>


  <item>
  <title>Movers roundup: Gilead Sciences, AMD</title>
  <description>Among the stock activity stories for Friday, July 18, from the AP Financial News: NEW YORK (AP)_ Shares of Gilead Sciences Inc. fell sharply Friday as Wall Street viewed the drug developer's latest earnings report as sign that the company could be shifting to a more subdued level of growth as its HIV treatments saturate the market.</description>
    <link>http://www.ibtimes.com/articles/20080718/movers-roundup-gilead-sciences-amd.htm</link> 
  <pubDate>Fri, 18 Jul 2008 16:02:12 EDT</pubDate>
  </item>


  <item>
  <title>Gilead shares fall on 2Q report, growth concerns</title>
  <description>Shares of Gilead Sciences Inc. fell sharply Friday as Wall Street viewed the drug developer's latest earnings report as sign that the company could be shifting to a more subdued level of growth as its HIV treatments saturate the market.</description>
    <link>http://www.ibtimes.com/articles/20080718/gilead-shares-fall-on-2q-report-growth-concerns.htm</link> 
  <pubDate>Fri, 18 Jul 2008 11:32:55 EDT</pubDate>
  </item>


  <item>
  <title>Earnings roundup: Microsoft, Google</title>
  <description>Among the earnings stories for Thursday, July 17, from AP Financial News: Top stories:</description>
    <link>http://www.ibtimes.com/articles/20080717/earnings-roundup-microsoft-google.htm</link> 
  <pubDate>Thu, 17 Jul 2008 18:08:45 EDT</pubDate>
  </item>


  <item>
  <title>Gilead 2Q profit rises on HIV drug sales</title>
  <description>Biotechnology company Gilead Sciences Inc. said Thursday its second-quarter profit rose 9 percent on sales of its HIV drugs Atripla and Truvada, which currently dominate the market.</description>
    <link>http://www.ibtimes.com/articles/20080717/gilead-2q-profit-rises-on-hiv-drug-sales.htm</link> 
  <pubDate>Thu, 17 Jul 2008 16:46:39 EDT</pubDate>
  </item>


  <item>
  <title>Earnings Preview: Gilead Sciences</title>
  <description>Gilead Sciences Inc. reports earnings for the second quarter on Thursday. The following is a summary of key developments and analyst opinion related to the period.</description>
    <link>http://www.ibtimes.com/articles/20080716/earnings-preview-gilead-sciences.htm</link> 
  <pubDate>Wed, 16 Jul 2008 11:38:35 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mostly lower Friday with the broader market as investors focused on troubles at mortgage companies Fannie Mae and Freddie Mac and oil prices continued climbing.</description>
    <link>http://www.ibtimes.com/articles/20080711/closing-glance-biotechnology.htm</link> 
  <pubDate>Fri, 11 Jul 2008 16:14:39 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Friday as the broader market declined on troubles at government-backed mortgage companies Fannie Mae and Freddie Mac, and oil prices continued climbing.</description>
    <link>http://www.ibtimes.com/articles/20080711/opening-glance-biotechnology.htm</link> 
  <pubDate>Fri, 11 Jul 2008 09:55:27 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mixed Thursday as the broader market rose slightly on Dow Chemical's multibillion dollar buyout bid for rival Rohm and Haas helped offset concerns about the financial sector and energy costs.</description>
    <link>http://www.ibtimes.com/articles/20080710/closing-glance-biotechnology.htm</link> 
  <pubDate>Thu, 10 Jul 2008 16:25:30 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened higher Thursday with the broader market on better-than-expected monthly sales reports and Dow Chemical Co.'s $15 billion buyout offer for Rohm and Haas Co.</description>
    <link>http://www.ibtimes.com/articles/20080710/opening-glance-biotechnology.htm</link> 
  <pubDate>Thu, 10 Jul 2008 09:41:12 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed mixed Wednesday as the broader market tumbled on rising oil prices and concerns over upcoming earnings reports in the technology and financial sectors.</description>
    <link>http://www.ibtimes.com/articles/20080709/closing-glance-biotechnology.htm</link> 
  <pubDate>Wed, 09 Jul 2008 16:33:52 EDT</pubDate>
  </item>


  <item>
  <title>Market Spotlight: Biotechnology Earnings Preview</title>
  <description>Biotech companies will likely be one of the few bright spots for investors this earnings season, as demand for essential medical treatments continues unabated despite the economic slowdown.</description>
    <link>http://www.ibtimes.com/articles/20080709/market-spotlight-biotechnology-earnings-preview.htm</link> 
  <pubDate>Wed, 09 Jul 2008 13:10:45 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Wednesday while the broader market slipped on rising oil prices. Here's how several key biotechnology stocks performed Wednesday:</description>
    <link>http://www.ibtimes.com/articles/20080709/opening-glance-biotechnology.htm</link> 
  <pubDate>Wed, 09 Jul 2008 10:03:29 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed higher Tuesday as analysts anticipate a mostly positive string of second-quarter earnings reports for key biotechnology companies in the coming weeks.</description>
    <link>http://www.ibtimes.com/articles/20080708/closing-glance-biotechnology.htm</link> 
  <pubDate>Tue, 08 Jul 2008 16:46:35 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened higher Tuesday as the broader market rose after Federal Reserve chairman Ben Bernanke said the central bank might extend its lending efforts to investment banks.</description>
    <link>http://www.ibtimes.com/articles/20080708/opening-glance-biotechnology.htm</link> 
  <pubDate>Tue, 08 Jul 2008 10:09:41 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology ends mixed</title>
  <description>Shares of biotechnology companies closed mixed Monday as the broader market fell over a cautious economic outlook from a Federal Reserve official and the possibility of more troubles in the financial sector.</description>
    <link>http://www.ibtimes.com/articles/20080707/closing-glance-biotechnology-ends-mixed.htm</link> 
  <pubDate>Mon, 07 Jul 2008 16:37:17 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Monday following the long holiday weekend, while the broader market gained ground as oil fell more than $5 a barrel. Early in the session, the Dow Jones Industrial average was up nearly 100 points.</description>
    <link>http://www.ibtimes.com/articles/20080707/opening-glance-biotechnology.htm</link> 
  <pubDate>Mon, 07 Jul 2008 09:43:29 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotech shares open mixed</title>
  <description>Shares of biotechnology companies opened mixed Thursday as the broader market rose after the Labor Department reported that the nation's unemployment rate held steady at 5.5 percent last month, easing concerns over a worsening job losses.</description>
    <link>http://www.ibtimes.com/articles/20080703/opening-glance-biotech-shares-open-mixed.htm</link> 
  <pubDate>Thu, 03 Jul 2008 09:39:14 EDT</pubDate>
  </item>


  <item>
  <title>Closing Glance: Biotechnology</title>
  <description>Shares of biotechnology companies closed lower with the broader market Wednesday as oil prices hit a new record and May factory orders showed the weakest performance in three months.</description>
    <link>http://www.ibtimes.com/articles/20080702/closing-glance-biotechnology.htm</link> 
  <pubDate>Wed, 02 Jul 2008 16:19:14 EDT</pubDate>
  </item>


  <item>
  <title>Opening Glance: Biotechnology</title>
  <description>Shares of biotechnology companies opened mixed Wednesday, while the broader market rose ahead of a Commerce Department report on factory orders that could give another glimpse of how the economy is faring.</description>
    <link>http://www.ibtimes.com/articles/20080702/opening-glance-biotechnology.htm</link> 
  <pubDate>Wed, 02 Jul 2008 09:47:00 EDT</pubDate>
  </item>


</channel>
</rss>